IGC Pharma (IGC) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Pharma (IGC) over the last 17 years, with Q3 2025 value amounting to -$1.2 million.
- Pharma's Enterprise Value rose 2529.11% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year increase of 2529.11%. This contributed to the annual value of -$405000.0 for FY2025, which is 6625.0% up from last year.
- Per Pharma's latest filing, its Enterprise Value stood at -$1.2 million for Q3 2025, which was up 2529.11% from -$454000.0 recorded in Q2 2025.
- In the past 5 years, Pharma's Enterprise Value ranged from a high of -$405000.0 in Q1 2025 and a low of -$14.6 million during Q1 2021
- Moreover, its 5-year median value for Enterprise Value was -$3.2 million (2023), whereas its average is -$5.4 million.
- Per our database at Business Quant, Pharma's Enterprise Value plummeted by 30232.48% in 2021 and then skyrocketed by 7510.96% in 2025.
- Quarter analysis of 5 years shows Pharma's Enterprise Value stood at -$11.9 million in 2021, then skyrocketed by 57.11% to -$5.1 million in 2022, then soared by 73.09% to -$1.4 million in 2023, then skyrocketed by 65.89% to -$470000.0 in 2024, then tumbled by 145.74% to -$1.2 million in 2025.
- Its Enterprise Value stands at -$1.2 million for Q3 2025, versus -$454000.0 for Q2 2025 and -$405000.0 for Q1 2025.